Skip to main content
. 2022 Dec 10;15:170. doi: 10.1186/s13045-022-01379-0

Fig. 1.

Fig. 1

Duration of remission, relapse-free survival, and overall survival for all phase 2 treated patients (N = 55). Kaplan–Meier estimates of the duration of remission by central assessment, with (A) and without (B) censoring of patients at subsequent allogeneic stem cell transplant. C Kaplan–Meier estimate of relapse-free survival by central assessment, with censoring of patients at subsequent allogeneic stem cell transplant. D Kaplan–Meier estimate of overall survival. CR = complete remission. CRi = complete remission with incomplete hematological recovery. Mo = month. NE = not estimable